Belemjian, Mark

Belemjian, Mark was paid $232K by Medicaid between Jan 2018 and Dec 2024, across 11 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 81% of everything it billed.

33Billing provider infoBELEMJIAN, MARK
EAST LONGMEADOW, MA 01028

33aNPI1417922816assigned 02/20/2006

33bProvider typePediatric Adolescent Medicine Physician

28Total paid$232K

24GClaims4,393

24DCodes billed11

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Pediatric Adolescent Medicine Physician providers in Massachusetts

Rank by total paid#19 of 54

Median peer was paid$119K

This provider vs. median1.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	724	$32K
2019	471	$23K
2020	329	$15K
2021	437	$28K
2022	895	$52K
2023	751	$41K
2024incomplete	786	$40K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	81%	2,620	2,364	$188K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	9.5%	391	369	$22K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	3.6%	414	413	$8K
96110	Developmental screening, with scoring and documentation, per standardized instrument	3.4%	719	719	$8K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	32	32	$2K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	42	40	$1K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	53	53	$645.37
87430		<1%	29	29	$373.23
90472	Immunization administration, each additional vaccine (list separately)	<1%	12	12	$282.96
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	18	17	$216.90
85018		<1%	63	63	$163.78

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.